PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $735 | +81.5% | 279,629 | +143.8% | 0.06% | +57.5% |
| Q2 2023 | $405 | +31.1% | 114,698 | +57.2% | 0.04% | +5.3% |
| Q4 2022 | $309 | -99.9% | 72,940 | -48.0% | 0.04% | -13.6% |
| Q3 2022 | $333,000 | +69.9% | 140,321 | +104.1% | 0.04% | +51.7% |
| Q2 2022 | $196,000 | -51.0% | 68,749 | -50.5% | 0.03% | -46.3% |
| Q1 2022 | $400,000 | -33.7% | 138,943 | +61.5% | 0.05% | -11.5% |
| Q3 2021 | $603,000 | +340.1% | 86,040 | +478.0% | 0.06% | +306.7% |
| Q2 2021 | $137,000 | -81.3% | 14,885 | -82.2% | 0.02% | -82.4% |
| Q4 2019 | $732,000 | +177.3% | 83,686 | +241.6% | 0.08% | +136.1% |
| Q3 2019 | $264,000 | -30.2% | 24,500 | -17.6% | 0.04% | -14.3% |
| Q2 2019 | $378,000 | +51.2% | 29,718 | +361.8% | 0.04% | +68.0% |
| Q1 2019 | $250,000 | -93.8% | 6,435 | -81.4% | 0.02% | -83.9% |
| Q2 2015 | $4,042,000 | +54.0% | 34,625 | +211.5% | 0.16% | +49.0% |
| Q1 2015 | $2,624,000 | +202.0% | 11,114 | +142.0% | 0.10% | +70.5% |
| Q4 2014 | $869,000 | -55.0% | 4,593 | -43.3% | 0.06% | -40.2% |
| Q3 2014 | $1,932,000 | +18.2% | 8,099 | -48.4% | 0.10% | -12.1% |
| Q1 2014 | $1,635,000 | +165.0% | 15,698 | +36.5% | 0.12% | +136.7% |
| Q3 2013 | $617,000 | +61.5% | 11,500 | +33.7% | 0.05% | +8.9% |
| Q2 2013 | $382,000 | – | 8,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |